1. Home
  2. EB vs MNPR Comparison

EB vs MNPR Comparison

Compare EB & MNPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eventbrite Inc.

EB

Eventbrite Inc.

N/A

Current Price

$4.51

Market Cap

442.9M

Sector

Technology

ML Signal

N/A

Logo Monopar Therapeutics Inc.

MNPR

Monopar Therapeutics Inc.

N/A

Current Price

$57.53

Market Cap

372.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EB
MNPR
Founded
2003
2014
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
442.9M
372.9M
IPO Year
2018
2019

Fundamental Metrics

Financial Performance
Metric
EB
MNPR
Price
$4.51
$57.53
Analyst Decision
Buy
Strong Buy
Analyst Count
2
13
Target Price
$5.00
$101.42
AVG Volume (30 Days)
998.4K
174.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
34.62
N/A
EPS
N/A
N/A
Revenue
$326,134,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.70
N/A
P/E Ratio
N/A
N/A
Revenue Growth
24.99
N/A
52 Week Low
$1.81
$26.06
52 Week High
$4.48
$105.00

Technical Indicators

Market Signals
Indicator
EB
MNPR
Relative Strength Index (RSI) 76.38 48.71
Support Level $4.43 $56.15
Resistance Level N/A $61.30
Average True Range (ATR) 0.02 3.39
MACD 0.00 0.72
Stochastic Oscillator 95.45 65.56

Price Performance

Historical Comparison
EB
MNPR

About EB Eventbrite Inc.

Eventbrite Inc is a self-service ticketing and experience technology platform that serves event creators. The company's two-sided marketplace connects creators and consumers every month to share their passions, artistry, and causes through live experiences. Creators use its self-service ticketing and marketing tools to plan, promote, and sell tickets to their events, and event seekers use its website and mobile application to discover and purchase tickets to experiences. Geographically, it generates maximum revenue from the United States. The company generates revenues principally from service fees and payment processing fees from the sale of paid tickets on its platform.

About MNPR Monopar Therapeutics Inc.

Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.

Share on Social Networks: